Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
TBX4 encodes a T-box transcription factor essential for lower limb development and is associated with ischio-coxopodopatellar syndrome (coxopodopatellar syndrome) (MONDO:0007841). Affected individuals present with patellar aplasia or hypoplasia, pelvic anomalies, and foot malformations. Heterozygous TBX4 variants disrupt developmental pathways governing ossification of the ischia and inferior pubic rami.
Early genetic evidence derived from a landmark study identifying putative loss-of-function mutations in six unrelated families with small patella syndrome, including nonsense, frameshift, splice-site, and missense changes in the conserved T-box domain (6 families, >6 probands) (PMID:15106123). Segregation was confirmed in multiple kindreds with autosomal dominant inheritance and concordant limb phenotypes.
Subsequent case reports have expanded the variant spectrum. A novel heterozygous frameshift c.113dup (p.Leu39fs) was detected in a 19-year-old proband and her father with recurrent patellar dislocation and confirmed small patella syndrome (PMID:29854702). More recently, a family with variable severity harbored a frameshift c.735del (p.Phe245LeufsTer25) segregating in four additional affected relatives (PMID:39467966).
The overall variant spectrum in coxopodopatellar syndrome includes at least eight distinct loss-of-function alleles: six truncating, one splice-site, and one frameshift variant, all acting in a dominant negative or haploinsufficient manner. A representative allele is c.721G>T (p.Glu241Ter).
Functional studies support haploinsufficiency as the pathogenic mechanism. Mesenchymal stem cells overexpressing TBX4 mutants (including c.1241C>T (p.Pro414Leu)) exhibit reduced differentiation, decreased FGF10 expression, and diminished promoter binding in chromatin immunoprecipitation and luciferase assays, consistent with impaired TBX4 regulation of limb morphogenesis (PMID:35216193).
Integration of genetic and experimental data establishes a definitive gene-disease relationship. Autosomal dominant TBX4 haploinsufficiency causes coxopodopatellar syndrome with highly penetrant skeletal anomalies. No conflicting evidence has been reported. Key take-home: TBX4 variant testing enables early diagnosis of coxopodopatellar syndrome and guides orthopedic management.
Gene–Disease AssociationDefinitiveHeterozygous TBX4 loss-of-function variants reported in six unrelated families (PMID:15106123), with segregation in two additional kindreds (PMID:29854702; PMID:39467966) and consistent phenotype over >20 y Genetic EvidenceStrongAutosomal dominant inheritance; eight distinct LoF/splice variants in eight probands; segregation confirmed in four additional relatives Functional EvidenceModerateIn vitro assays demonstrate reduced TBX4 binding to FGF10 promoter and impaired MSC differentiation consistent with haploinsufficiency (PMID:35216193) |